West German Cancer Center (WTZ), University Hospital Essen
One of Germany's oldest and largest cancer centres, home to the West German Proton Therapy Centre and a leading melanoma and theranostics programme.
Overview
Founded in 1967, the Westdeutsches Tumorzentrum at University Hospital Essen was among the first German Cancer Aid Oncology Centers of Excellence and became a National Center for Tumor Diseases site (NCT West, with Cologne) in 2023. It operates the West German Proton Therapy Centre Essen (WPE), Europe's largest university-based proton facility, treating many paediatric patients. The dermato-oncology group under Dirk Schadendorf has led melanoma immunotherapy and adjuvant trials, and the nuclear medicine department under Ken Herrmann is a high-volume theranostics centre for PSMA and somatostatin-receptor radioligands. Other strengths include sarcoma, uveal melanoma, stem cell transplantation and neuro-oncology.
- West German Proton Therapy Centre
- Melanoma and dermato-oncology
- Theranostics and nuclear medicine
- Stem cell transplantation
- NCT West
Nuclear medicine leader who co-led VISION and runs one of the world's largest theranostics programmes.
A German nuclear medicine doctor at Essen who helped design a scoring system, RECIP, for reading follow-up PSMA scans in prostate cancer patients on lutetium therapy, and who co-writes the field's international imaging guidelines.
Similar pages
not linked directly; found by shared links- InstitutionUppsala University Hospital / Uppsala University
Shares IBA (Ion Beam Applications), Lutetium-177 dotatate, Neuroendocrine tumours, Radioligand therapy (beta emitters).
- InstitutionIRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori' (IRST)
Shares Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan, Neuroendocrine tumours, PSMA PET.
- InstitutionInselspital, Bern University Hospital / University Cancer Center Inselspital
Shares Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan, Neuroendocrine tumours, PSMA PET.
- PersonPhillip H. Kuo
Shares VISION, Lutetium-177 vipivotide tetraxetan, PSMA PET.
- InstitutionTUM Klinikum rechts der Isar / CCC München
Shares Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan, Neuroendocrine tumours, PSMA PET.
- PersonRahul Aggarwal
Shares Lutetium-177 vipivotide tetraxetan, PSMA PET, Radioligand therapy (beta emitters), Prostate cancer.
- InstitutionUniversity Hospital Düsseldorf / CIO Düsseldorf
Shares Lutetium-177 vipivotide tetraxetan, Neuroendocrine tumours, PSMA PET, Radioligand therapy (beta emitters).
- PersonJohannes Czernin
Shares Lutetium-177 vipivotide tetraxetan, PSMA PET, Radioligand therapy (beta emitters), Prostate cancer.